Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Method
1.1.2. Procedure
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.6. Data for primary interviews in North America
1.3.7. Data for primary interviews in Europe
1.3.8. Data for primary interviews in Asia Pacific
1.3.9. Data for primary interviews in Latin America
1.3.10. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Volume price analysis (Model 2)
1.6.2. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Method outlook
2.2.2. Procedure outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Global Coronary Artery Bypass Graft Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increase in prevalence of cardiovascular diseases
3.4.1.2. Growing prevalence of hypertension
3.4.1.3. Rising technological advancement
3.4.1.4. Favorable reimbursement scenario
3.4.2. Market restraint analysis
3.4.2.1. Shortage of skilled workforce
3.4.2.2. Complications/risks associated with the surgery
3.5. Coronary Artery Bypass Graft Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Coronary Artery Bypass Graft Market : Method Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Off-pump
4.1.2. On-pump
4.1.3. Minimally Invasive Direct
4.2. Method Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Coronary Artery Bypass Graft Market by method Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Off pump
4.5.1.1. Off pump market estimates and forecast 2018 to 2030 (USD Billion)
4.5.2. On pump
4.5.2.1. On pump market estimates and forecast 2018 to 2030 (USD Billion)
4.5.3. Minimally invasive direct
4.5.3.1. Minimally invasive direct market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 5. Coronary Artery Bypass Graft Market : Procedure Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Single CABG surgery
5.1.2. Double CABG surgery
5.1.3. Triple CABG surgery
5.1.4. Quadruple CABG surgery
5.2. Procedure Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Coronary Artery Bypass Graft Market by Procedure Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Single CABG surgery
5.5.1.1. Single CABG surgery market estimates and forecast 2018 to 2030 (USD Billion)
5.5.2. Double CABG surgery
5.5.2.1. Double CABG surgery market estimates and forecast 2018 to 2030 (USD Billion)
5.5.3. Triple CABG surgery
5.5.3.1. Triple CABG surgery market estimates and forecast 2018 to 2030 (USD Billion)
5.5.4. Quadruple CABG surgery
5.5.4.1. Quadruple CABG surgery market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 6. Coronary Artery Bypass Graft Market: End-Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Cardiology centers
6.1.3. Others
6.2. End-use Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Coronary Artery Bypass Graft Market by End-Use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Billion)
6.5.2. Cardiology centers
6.5.2.1. Cardiology centers market estimates and forecast 2018 to 2030 (USD Billion)
6.5.3. Others
6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 7. Global Coronary Artery Bypass Graft Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
7.7. North America
7.7.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.8. Europe
7.8.1. UK
7.8.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.8.6. Sweden
7.8.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.8.7. Norway
7.8.7.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.8.8. Denmark
7.8.8.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.9. Asia Pacific
7.9.1. China
7.9.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.9.2. Japan
7.9.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.9.4. Australia
7.9.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.9.5. Thailand
7.9.5.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.9.6. South Korea
7.9.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.11.2. South Africa
7.11.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Billion)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Company Profiles
8.4. Heat Map Analysis
8.4.1. Medtronic
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. TERUMO CORPORATION
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Guidant Group
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. MAQUET Holding B.V. & Co.KG
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Novadaq Technologies Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. KARL STORZ GmbH & Co. KG
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Edwards Lifesciences
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Genesee Biomedical Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Sorin Group
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer